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A B S T R A C T
Gastric metaplasia is one of the factors in duodenal ulcer appearance. The aim of
this study was to investigate the frequency of gastric metaplasia and its connection with
age, sex, cigarette smoking and H. pylori infection. In the study 216 patients were in-
cluded. There were 98 patients with duodenal ulcer, 60 with duodenitis, and 58 healthy
control subjects. There was no statistically significant difference in gastric metaplasia
frequency according to age and sex. Gastric metaplasia was statistically more signifi-
cant in patients with duodenal ulcer (p < 0.01). In all the subjects cigarette smoking did
not significantly influence gastric metaplasia. In smokers with duodenal ulcer, and tho-
se who besides duodenal ulcer and smoking had H. pylori infection gastric metaplasia
was more frequent (p < 0.01). However, in patients with duodenal ulcer, there was no
statistically significant difference of gastric metaplasia related to H. pylori presence. It
may be suggested that H. pylori infection is not of indispensable significance for gastric
metaplasia appearance.
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Introduction
Gastric metaplasia or the appearance
of gastric type mucous cells within the
duodenal epithelium is a common finding
of biopsy specimens from the patients
with duodenitis or duodenal ulcer1,2. It
can be found in healthy individuals, but
in lesser extent3. An assumption is that
the gastric metaplasia is a protective me-
chanism against persistently high con-
centrations of gastric acid in the duode-
nal bulb. Generally, it is assumed that
gastric metaplasia arises from the neck of
Brunner´s glands as a result of persis-
tently increased concentration of acidity
in the duodenal bulb. However, gastric
metaplasia can also develop as a non-spe-
cific response to mucosal injury unrelated
to acid peptic damage4.
As the colonization of Helicobacter py-
lori is limited to a gastric type of epithe-
lium5,6 the presence of gastric metaplasia
in duodenum allows H. pylori to colonize
the duodenum and to cause active inflam-
mation. Inflammed duodenal mucosa be-
comes susceptible to acid damage, which
leads to ulceration7. Prevalence of gastric
metaplasia is not influenced by H. pylo-
ri7–9, but its extent is higher in Helico-
bacter pylori positive individuals10, as-
suming that H. pylori may be responsible
for spreading of preexisting gastric me-
taplasia.
The aim of this study was to deter-
mine the prevalence of gastric metaplasia
and Helicobacter pylori, especially even-
tual relationship of Helicobacter and gas-
tric metaplasia in the patients with duo-
denal ulcer and duodenitis.
Materials and Methods
Subjects
Three groups of patients were inclu-
ded in this study: 98 with duodenal ulcer,
60 with duodenitis and 58 controls. Duo-
denal ulcer and duodenitis were diag-
nosed by endoscopy of upper gastrointes-
tinal tract in patients with positive ana-
mnesis of dyspeptic complaints, and con-
firmed histopathologically.
Patients with anamnesis of hemorrha-
gic diathesis or coagulation defects, ma-
lignancy of esophagus, gastric or duode-
nal malignancy as well as patients who
underwent gastric surgery, or those hav-
ing insulin dependent diabetes mellitus,
were excluded from the study. None of the
control subjects had any significant medi-
cal history or any gastrointestinal symp-
toms. They had a completely normal en-
doscopy. No aspirin or other NSAID, an-
tacid or H2 receptor antagonist had been
taken at least four weeks before, or dur-
ing the study. All subjects gave an in-
formed consent to the study that was ap-
proved by the Hospital Ethical Commit-
tee.
Endoscopy
Endoscopy was performed in the mor-
ning after an overnight fast with an Olym-
pus GIF, type Q20 (Olympus Optical Co.,
Ltd., Tokyo, Japan). Smooth, clear and in-
tact mucosa was considered a normal
finding. Duodenal mucosa injury of over
0.5x0.5 cm was considered a duodenal ul-
cer. The endoscopically visible changes in
duodenal mucosa pertinent to the non-
specific chronic duodenitis were classified
according to Stephen et al.11 as: 0 = nor-
mal appearance; 1 = mucosal hyperemia;
2 = edematous hyperemic mucosa that
bleeds to the touch; and 3 = same as pre-
vious, but including »pepper and salt«
changes. The positive findings included
degrees 1, 2 and 3 of the changes.
Biopsy specimens
The determination of H. pylori pres-
ence required taking three biopsy speci-
mens from the antrum of the gastric mu-
cosa, 2 cm from the pylorus by biopsy
forceps (Olympus FB 24-K). One speci-
men was intended for a quick urease test
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(CLO-test), and two for culture using
standard methods. H. pylori was inden-
tified by morphological and biochemical
tests for oxidase, catalase and urease ac-
tivity (Merck, Darmstadt, Germany). The
presence of H. pylori in the antral mucosa
was confirmed only if both tests were pos-
itive. Four specimens from the duodenal
mucosa were used to determine the de-
gree of duodenitis by somewhat modified
method of Witehead et al.12. The duode-
nal histological findings were reported as
follows: degree 1: normal appearance of
the surface epithelium, mild edema, cel-
lular infiltrate, predominantly into the
cellular plasma; degree 2: generally nor-
mal occurrence of the surface epithelium,
randomly distributed and thick inflam-
matory infiltrate of the lamina propria
spreading deep bellow to Bruner's glands;
degree 3: ulceration of the surface epithe-
lium, considerable inflammatory infiltra-
te of the lamina propria, some crypts and
parts of the surface epithelium perme-
ated with neutrophils. The positive find-
ings referred to changes of the degrees 2
and 3. Duodenal biopsy specimens were
stained with periodic acid Schiff (PAS) for
the detection of metaplastic gastric epi-
thelium. The presence and degree of duo-
denal inflammation were graded accord-
ing to Wyatt´s classification.
Statistical analysis
The results are expressed as mean 
SD. Statistical evaluation of the data was
based on Student’s t-test for unpaired
data and Schee’s test for the analysis of
variance to determine respective differ-
ences between smokers and nonsmokers,
and between H. pylori positive and nega-
tive patients. Differences associated with
probability values of p < 0.05 were consid-
ered statistically significant.
Results
In the group of 216 patients (132 men
and 84 women) aged 19 to 65 years (mean
age 45.42 years) there were 98 patients
with duodenal ulcer, 60 with duodenitis
and 58 healthy control subjects. Helico-
bacter pylori infection was confirmed in
136 out of 216 patients (63%). Gastric
metaplasia was present in 120 patients
(56%). In 136 Helicobacter positive pa-
tients gastric metaplasia was present in
100 patients (74%). In the patients with
duodenal ulcer, the incidence of Helico-
bacter pylori infection was significantly
higher (86%) in relation to the patients
with duodenitis (60%) and healthy sub-
jects (28%) (Table 1).
Presence of gastric metaplasia was
significantly higher in the patients with
duodenal ulcer (90%) than in the healthy
subjects (24%) and the patients with duo-
denitis (30%), (p < 0.01), (Table 2).
Prevalence of concomitant occurrence
of GM and HP was significantly higher in
the group of patients with duodenal ulcer
(78%) in relation to other two groups (Ta-
ble 3), (p < 0.01).
H. pylori patients with duodenal ulcer
had significantly higher incidence of GM
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TABLE 1
PREVALENCE OF H. PYLORI ACCORDING TO GASTRIC METAPLASIA
Group of patients N GM present GM absent Total
Control 58 10/14 (71.4%)* 6/44 (13.6%)* 16/58 (28%)
Duodenitis 60 14/18 (77.7%)** 22/42 (52.9%)** 36/60 (60%)
Duodenal ulcer 98 76/88 (86.3%) 8/10 (80%) 84/98 (86%)
Student’s test: *p < 0.01; **p < 0.05.
(90%), than H. pylori patients with duo-
denitis (30%), (Table 2), (p < 0.01).
There were no statistically significant
differences in occurrence of gastric me-
taplasia in men (55%) and women (57%).
There were no significant differences in
presence of gastric metaplasia in differ-
ent age groups (Table 4) (X2 = 4.25¸ p >
0.05). In Helicobacter pylori positive sub-
jects there is no statistically significant
difference in occurrence of gastric meta-
plasia regarding the sex while in Helico-
bacter negative subjects prevalence of
gastric metaplasia was higher in women
(X2 = 0.14; p > 0.05), (Table 4).
There is no statistically significant dif-
ference in presence of gastric metaplasia
among Helicobacter pylori positive and
Helicobacter pylori negative patients
with duodenal ulcer (X2 = 0.17, p > 0.05),
(Table 2). In the patients with duodenal
ulcer, gastric metaplasia was present in
76 out of 84 Helicobacter positive pa-
tients (90%), while in 14 Helicobacter ne-
gative patients with duodenal ulcer gas-
tric metaplasia was present in 12 (86%),
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TABLE 2
PREVALENCE OF GASTRIC METAPLASIA ACCORDING TO H. PYLORI
Group of patients N H. pylori present H. pylori absent Total
Control 60 6/16 (37.5%) 8/42 (19%) 14/58 (24%)
Duodenitis 58 14/36 (39%)* 4/24 (16.6%) 18/60 (30%)
Duodenal ulcer 98 76/84 (90.5%) 12/14 (85.7%) 88/98 (90%)
Student’s t-test: *p < 0.01.
TABLE 3
PREVALENCE OF GASTRIC METAPLASIA AND HELICOBACTER PYLORI
Group of patients N GM+ HP+ GM+ HP– GM– HP+ GM–HP–
Control 58 10 (17%) 4 6 38 (65%)**
Duodenitis 60 14 (23%) 4 22 (37%)** 20
Duodenal ulcer 98 76 (78%)* 12 8 2
Total 216 100 20 36 60
HP: Helicobacter pylori; GM: gastric metaplasia
Student’s t-test, *p < 0.01 in relation to the control and dudenitis; **p < 0.05 in relation to the
control and duodenal ulcer; **p < 0.05 in relation to duodenitis and duodenal ulcer.
TABLE 4
PREVALENCE OF GASTRIC METAPLASIA IN RELATION TO AGE, SEX, AND H. PYLORI
Prevalence
Age (y) HP+ve male HP+ve female HP-ve male HP-ve female Total
20–39 18/28 4/6 2/14 6/16 30/64 (47%)
40–59 42/52 26/36 4/28 8/20 80/136 (59%)
>60 6/8 4/6 0/2 0 10/16 (63%)
Total 66/88 (75%) 34/48 (71%) 6/44 (14 %) 14/36 (39%)
HP: Helicobacter pylori
(Table 2). In the population without duo-
denal ulcer there was statistically signifi-
cant difference between Helicobacter py-
lori positive and Helicobacter pylori nega-
tive subjects and appearance of gastric
metaplasia (X2 = 12.17, p < 0.001), (Table
2).
There is no statistically significant dif-
ference in occurrence of gastric metapla-
sia in all patients regarding smoking sta-
tus (X2 = 0.048, DF = 2; p > 0.05) as well
as in Helicobacter positive patients (X2 =
2.72, DF = 2; p > 0.05), (Table 6). Preva-
lence of gastric metaplasia is higher in
smokers with duodenal ulcer than in non-
smokers with the same disease. Gastric
metaplasia was statistically significantly
higher in Helicobacter positive smokers
than in Helicobacter negative non-smo-
kers (p < 0.05, Table 6).
Discussion
It is known that duodenal ulcer dis-
ease is related to the excess secretion of
gastric acid13,14. But, other factors, in-
cluding Helicobacter pylori play an im-
portant role in the pathogenesis of duode-
nal ulcer disease7,15–18. In our study we
found significantly higher incidence of H.
pylori as well as gastric metaplasia in the
patients with duodenal ulcer than in the
healthy subjects (controls), which is in ac-
cordance to the literature19,20.
It appears, however that only the mi-
nority of the patients infected with He-
licobacter pylori develop duodenal ulcer
while the majority of the patients with
gastric metaplasia belong in a group with
duodenal ulcer21–25. In our study we
found that the prevalence of gastric me-
taplasia is significantly higher in the pa-
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TABLE 5
PREVALENCE OF GASTRIC METAPLASIA IN RELATION TO H. PYLORI
AND SMOKING OF CIGARETTES
Smoking
H. pylori present H. pylori absent
TotalDuodenal ulcer Duodenal ulcer
Absent Present Total Absent Present Total
Non-smoking 10/20 28/36 (77%)** 38/56 (68%) 2/26 4/6 6/32 (19%) 44/88 (50%)
Smoking
<15 cig/d 10/22 34/34 (100%) 44/76 (58%) 2/18 2/2 4/20 (20%) 48/96 (50%)
>15 cig/d 6/10 14/14 (100%) 20/24 (83%)* 4/22 6/6 10/28 (36%) 30/52 (57%)
Variance analisis: Schefee’s test, **p < 0.05 in relation to smoking;
*p < 0.05 in relation to smoking >15 cig/d.
TABLE 6
PREVALENCE OF GASTRIC METAPLASIA IN








Patrick et al. 75%
Kreuning et al. 64%
Greenlaw et al. 60%
Shousha et al. 39%
Wyatt et al. 65%
Fizgibbons et al. 22%
Carrick et al. 92%
Tucci et al. 30% 40-90%
Offerhaus et al. 88%
Noach et al. 90%
Bago et al. 28% 90%
tients with duodenal ulcer than in the
healthy subjects and the patients with
duodenitis. There is still an open ques-
tion whether the appearance of gastric
metaplasia is a consequence of high acid
secretion4,7,26,27 (that is proved by the low
incidence of gastric metaplasia in hypo-
secretors of gastric acid, lack of gastric
metaplasia in patients with atrophic gas-
tritis and low incidence of gastric meta-
plasia two years following vagotomy2,28)
or gastric metaplasia appears primarily
rendering the mucosa more susceptible to
gastric acid29.
On the other hand some authors claim
that gastric metaplasia presents even a
protective factor against gastric acid (sin-
ce it is more common on the edges of duo-
denal ulcer than in other areas of duode-
num)30–32.
The results of our study have shown
no direct relationship between occurrence
of gastric metaplasia and Helicobacter
pylori in the patients with duodenal ul-
cer, which is in concordance with some
authors8,9,33, but renders open a possibil-
ity of Helicobacter’s indirect (together
with other factors) influence on the ap-
pearance of gastric metaplasia through
inducement the gastric acid hypersecre-
tion. The finding that the prevalence of
gastric metaplasia is higher in Helico-
bacter positive patients suggests that He-
licobacter infection could be responsible
for spreading of gastric metaplasia4 by
causing hypersecretion of gastric acid,
thereby increasing duodenal acidity34–36.
The results of some studies in which era-
dication of Helicobacter resulted in re-
gression of inflammation and extent of
gastric metaplasia37 are in the accordance
to the previos statement.
In our study Helicobacter pylori ap-
pears more commonly in the areas of gas-
tric metaplasia. In the patients with duo-
denal ulcer and Helicobacter, gastric me-
taplasia was present in 90%, but gastric
metaplasia was present in 86% of the
Helicobacter negative patients with duo-
denal ulcer as well. It seems that
Helicobacter pylori and gastric metapla-
sia are two (independent?) etiological fac-
tors in breaking the duodenal mucosas
resistance on the way toward the duode-
nal ulcer disease.
Some authors consider gastric meta-
plasia as a primary event (protective
against lesion caused by gastric acid)
which makes a susceptible environment
for Helicobacter colonization leading to
the inflammation15,38. The prevalence of
Helicobacter pylori was significantly hi-
gher than the prevalence of gastric meta-
plasia in the patients with duodenitis (36
against 18), which was not case in the pa-
tients with duodenal ulcer disease, where
the incidence of gastric metaplasia was
even somewhat higher than the incidence
of Helicobacter (88 against 84 of 98 pa-
tients with duodenal ulcer).
The increased prevalence of Helico-
bacter pylori is evident in the patients
with duodenal ulcer group in comparison
with groups with duodenitis and healthy
subjects. The prevalence of gastric me-
taplasia is, however, more increased in
the patients with duodenal ulcer, than in
other two groups. Similar results were
found by other authors19,20,24,39,40. Accord-
ing to some studies, a capacity of gastric
hypersecretion is unchanged following
the eradication of Helicobacter pylori, so
it can be concluded that gastric meta-
plasia is a more serious risk factor for the
development of duodenal ulcer disease
than Helicobacter pylori, or Helicobacter
is only »following« gastric metaplasia (co-
lonizing mucosa like »gastric one«) caus-
ing by itself no duodenal ulcer disease21.
We could say that gastric metaplasia is
an original event that arises as a protec-
tion mechanism to the increased secre-
tion of gastric acid, while the second
event is colonization of Helicobacter that
causes the inflammation16,38. It is sup-
ported by the constantly (in all three
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groups) high correlation between the ap-
pearance of H. pylori and the presence of
gastric metaplasia.
Gastric metaplasia is an almost con-
stant finding in the patients with duode-
nal ulcer4,14,28,38,40. A finding that a high
percent of healthy subjects is infected
with Helicobacter pylori, while the preva-
lence of gastric metaplasia in healthy
subjects is low, provides another piece of
evidence for a hypothesis that gastric me-
taplasia is more important factor in pa-
thogenesis of duodenal ulcer disease. On
the other hand, gastric metaplasia in the
patients with duodenitis and healthy
subjects appeared statistically more often
in Helicobacter positive than in Helico-
bacter negative patients (this was not the
case in the patients with duodenal ulcer).
One of the reasons why we observed this
pattern was a fact that a small group of
patients with duodenal ulcer disease and
Helicobacter negativity was observed,
and the second one was caused by the in-
dependence of gastric metaplasia and He-
licobacter, but rather its dependance on
hyperacidity41.
In our study we have shown no signifi-
cant difference in the prevalence of gas-
tric metaplasia according to sex in He-
licobacter positive patients. There was
also no statistically significant difference
in the incidence of Helicobacter in differ-
ent age groups. Similar results were re-
ported in the literature14..We could also
conclude that gastric metaplasia is a pri-
mary factor (protective against lesions
caused by gastric acid) that makes a sus-
ceptible environment for Helicobacter co-
lonization which leads to the inflamma-
tion16,38. Results of our study show signi-
ficantly higher prevalence of gastric me-
taplasia in the patients with duodenal ul-
cer in comparison to those with duode-
nitis (compatible with the results of other
authors2,22,24,39,40.
The finding of significantly higher
prevalence of gastric metaplasia in the
patients with duodenitis found in the
study of Noach et al.14 can be explained
by the utilised methodology and a place of
sample taking. In the patients with duo-
denitis we took samples from the areas of
the most clear changes of the anterior
wall of bulb and from the edge of ulcus in
the duodenal ulcer patients. It is clear
that this could cause such result discrep-
ancies, as mentioned in the study of Mar-
shall et al.41, where the appearance of
gastric metaplasia was higher in samples
taken from the edge of duodenal ulcer in
comparison with the other areas of ulcer
(63%).
According to our results there is a re-
lationship between the occurrence of gas-
tric metaplasia and Helicobacter infec-
tion, especially in the patients with duo-
denal ulcer. The same suggests that gas-
tric metaplasia arises as a response to
high output of gastric acid42 with distur-
bance of gastroantral segment motility,
and/or rapid emptying and consequent
colonization of duodenum21. It should cer-
tainly be that at the same level, there is
consequent duodenitis, which in fact is
just a step toward ulceration process.
This theory is supported by the results of
this study, where the prevalence of gas-
tric metaplasia is higher in the patients
with duodenitis compared with the heal-
thy subjects. As a proof of this statement
there is also a high concordance of duode-
nal ulcer disease and duodenitis in the
same patients43. However, the role and
the importance of duodenitis in the devel-
opment of duodenal ulcer is not yet clear.
The basic question is whether the duo-
denitis appears before duodenal ulcer dis-
ease, in the same time, or is it the conse-
quence (residua) of ulcer disease. A high
percent of our patients with duodenitis
had positive H. pylori (60%) as well as
gastric metaplasia, thus implying similar
pathogenetic events if duodenitis is to be
assumed as one step in duodenal ulcer
development43. Smoking is a risk factor
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in development44 and recurrence of peptic
ulcer45 with influences badly upon ulcer
healing46. By decreasing cytoprotective
prostaglandins47, smoking can cause duo-
denal mucosa damage. In our study in all
patients there was no significant differ-
ence in the appearance of gastric meta-
plasia with respect to smoking. Signifi-
cant increase of prevalence of gastric
metaplasia in the patients with duodenal
ulcer, however, implies that smoking has
an important role in pathogenesis of duo-
denal ulcer disease. We have also found
that smokers with duodenal ulcer and
Helicobacter pylori infection had higher
prevalence of gastric metaplasia that
speaks in favour of possible synergistic
activity of these two etiopathogenic fac-
tors upon duodenal ulcer disease appear-
ance.
R E F E R E N C E S
1. MARSHALL, B. J., C. S. GOODWIN, J. R.
WARREN, R. MURRAY, E. D. BLINCOW, S. J.
BLACKBOURN, Lancet, II (1988)1437. — 2. WYATT,
J. I., B. J. RATHBONE, M. F. DIXON, R. V. HEAT-
LEY, J. Clin. Pathol., 40 (1987) 841. — 3. KRE-
UNING, J., F. T. BOSMAN, G. KUIPER, A. M. vd
WAL, J. LINDENMAN, J. Clin. Pathol., 31 (1978) 69.
— 4. WYATT, J. I., B. J. RATHBONE, G. M. SOBALA,
T. SHALLCROSS, R. V. HEATLEY, A. T. R. AXON, J.
Clin. Pathol., 43 (1990) 981. — 5. JOHAN, G., A.
OFFERHAUS, E. N. MOLYVAS, P. J. HOE-
DEMAEKER, J. Pathol., 162 (1990) 239. — 6. MAD-
SEN, J. E., K. VETVIK, S. AASE, APMIS, 99 (1991)
997. — 7. WALKER, M. M., J. E. CRABTREE, Ann.
NY Acad. Sci., 859 (1998) 96. — 8. FRIERSON, H. J.,
S. H. CALDWELL, B. J. MARSHALL, Mod. Pathol., 3
(1990) 271. — 9. KREUNING, J., A. M. WALL, G.
KUIPER, J. LINDENMAN, Scand. J. Gastroenterol.,
167 (1989) 16. — 10. WITEHEAD, R., R. ROCA, D. D.
MIKLE, J. DKINER, S. C. TRUELOVE, Dig. Dis., 13
(1975) 129. — 11. STEPHEN, J. G., M. LESNA, C. W.
WENEBLES, Br. J. Surg., 65 (1978) 438. — 12.
NOACH, L. A., T. M. ROLF, N. B. BOSMA, M. P.
SCHWARTZ, J. OOSTING, E. J. A. RAUWS, G. N. J.
TYGTAT, Gut, 34 (1993) 1510. — 13. SAVARINO, V.,
G. S. MELA, P. ZENTILIN, M. R. MELE, L. LAPER-
TOSA, R. PATETTA, E. DALLORTO, A. VASSALO,
C. MANSI, S. VIGNERI, G. CELLE, Gut, 39 (1996)
508. — 14. WORMSLEY, K. G., Gut, 15 (1974) 59. —
15. RAUWS, E. A. J., W. LANGENBERG, H. J.
HOUTHOFF, H. C. ZANEN, G. N. J. TYGTAT, Ga-
stroenterology, 94 (1988) 33. — 16. MARSHALL, B.
J., J. A. ARMSTRONG, D. B. Mc GECHIE, R. J.
GLANCY, Med. J. Aust., 142 (1985) 436. — 17. FU-
TAMI, H., M. TAKASHIMA, T. FURUTA, H. HANAI,
E. KANEKO, J. Gastroenterol. Hepatol., 14 (1999)
114. — 18. PEURA, D. A., Am. J. Gastroenterol., 92
(1997) 8S. — 19. SOLCIA, E., L. VILLANI, R. FIOC-
CA, O. LUINETTI, R. BOLDORINI, E. TRESPI, M.
PEREGO, C. ALVISI, M. LAZZARONI, G. BIANCHI
PORRO, Scand. J. Gastroenterol., 201 (1994) 28. —
20. HSU, T. C., C. YEH, H. H. CHENG, Journal of
Formosan Medical Association, 91 (1992) 81. — 21.
WYATT, J. I., B. J. RATHBONE, M. F. DIXON, R. V.
HEATLEY, A. T. R. AXON, Lancet, (1988) 118. — 22.
TUCCI, A., D. SUSI, I. BOVANI, Gastroenterology,
98 (1990) A 141. — 23. JAMES, A. J., Gut, 5 (1964)
285-94. — 24. GREENLAW, R., D. G. SHEAHAN, V.
De LUCA, D. MILLER, D. MYRESON, P. MYRE-
SON, Dig. Dis. Sci., 25 (1980) 660. — 25. PATRICK,
W. J. A., D. DENHAM, A. P. M. FORREST, Gut, 15
(1974) 767. — 26. CASELLI, M., L. TREVISANI, A.
ALEOTTI, M. R. BOVOLENTA, G. STABELLINI,
Dig. Dis. Sci., 34 (1989) 1374. — 27. CARRICK, J., A.
LEE, S. HAZELL, M. RALSTON, G. DASKALOPOU-
LOS, Gut, 30 (1989) 790. — 28. WYATT, J. I., B. J.
RATHBONE, Gastroenterol. Clin. Biol., 13 (1989)
78B. — 29. BODE, G., P. MALFERTHEINER, C.
KULLMAN, H. DITSCHUNEIT, Gastritis and duo-
denal ulcer: lecitin-binding characteristics of Campy-
lobacter pylori infected and non-infected surface mu-
cosu cells. In: MEDGRAUD, F., H, LAMOULIATTE
(Eds.): Gastroduodenal pathology and Campylobac-
ter pylori. (Elsevier, New York, 1989). — 30. FULL-
MAN, H., G. Van DEVENTER, D. SCHEIDMAN, J.
WALSH, J. ELASHOFF, W. WEINSTEIN, Gastroen-
terology, 88 (1985) 1390. — 31. GRAHAM, D. J., Gas-
troenterology, 96 (1989) 615. — 32. URAKAMI, Y., M.
KIMURA, H. SEKI, Jap. J. Gastroenterol., 93 (1996)
893. — 33. KIM, N., S. H. LIM, K. H. LEE, S. E.
CHOI, J. Clin. Gastroenterol., 27 (1998) 246. — 34.
MOSS, S., J. CALAM, Gut, 34 (1993) 888. — 35. LE-
VI, S., K. BEARDSHALL, G. HADDAD, R. PLAY-
FORD, P. GHOSH, J. CALAM, Lancet, 1 (1989) 1167.
— 36. EL-OMAR, E., I. PENMAN, C. A. DIORRIAN,
J. E. S. ARDILL, K. E. L. Mc COLL, Gut, 34 (1993)
1060. — 37. KHULUSI, S., S. BADVE, P. PATEL, R.
LLOYD, J. M. MARRERO, C. FINLAYSON, M. A.
MENDALL, T. C. NORTHFIELD, Gastroenterology,
110 (1996) 455. — 38. DIXON, M. F., J. I. WYATT,
BMJ, 302 (1991) 1535. — 39. YANG, H., M. F. DI-
XON, J. ZUO, F. FONG, D. ZHOU, I. CORTHESY, A.
BLUM, J. Clin. Gastroenterol., 20 (1995) 110. — 40.
FITZGIBONS, P. L., C. P. DOOLEY, H. COHEN, M.
D. APPLEMAN, Am. J. Clin. Pathol., 90 (1988) 711.
— 41. RAUWS, E. A. J., G. N. J. TYGTAT, Lancet, I
164
J. Bago et al.: Duodenal Ulcer and Duodenitis, Coll. Antropol. 24 (2000) 1: 157–165
(1990) 1233. — 42. SHOUSHA, S., I. G. BARRISON,
W. EL-SAYED, S. KHAN, R. A. PARKINS, Dug. Dis.
Sci., 29 (1984) 311. — 43. BAGO, J., M. RENI], N.
KU^I[EC, Coll. Antropol., 21 (1997) 507. — 44.
FRIEDMAN, G. D., A. B. SIEGLANB, C. C. SELT-
ZER, N. Eng. J. Med., 290 (1974) 469. — 45. SON-
NENBERG, A., S. A. MULLER, E. VOGEL, Gastro-
enterology, 81 (1981) 1061. — 46. IPPOLITI, A., J.
ELASHOF, J. VALENZUELA, Gastroenterology, 85
(1983) 875. — 47. BAGO, J., M. KLJAJI] TURKELJ,
N. KU^I[EC, Croat. J. Gastroenterol. Hepatol., 4
(1995) 59.
J. Bago
Department of Hepatogastroenterology, Internal Medicine Clinic, General Hospital
»Sv. Duh«, Sv. Duh 64, 10000 Zagreb, Croatia
POVEZANOST @ELU^ANE METAPLAZIJE S DOBI, SPOLOM, PU[ENJEM
I HELICOBACTER PYLORI INFEKCIJOM U BOLESNIKA S
DUODENALNIM ULKUSOM I DUODENITISOM
S A @ E T A K
@elu~ana metaplazija je jedan od ~imbenika u nastanku ulkusa dvanaesnika. Na-
mjera ove studije bila je istra`iti u~estalost `elu~ane metaplazije, te njenu povezanost s
dobi, spolom, pu{enjem i H. pylori infekcijom. U istra`ivanje je bilo uklju~eno 216 ispi-
tanika, od ~ega 98 s ulkusom dvanaesnika, 60 s duodenitisom i 58 zdravih ispitanika.
Nije bilo statisti~ki zna~ajne razlike kod u~estalosti `elu~ane metaplazije po dobi i spo-
lu. @elu~ana metaplazija je bila statisti~ki zna~ajno ve}a u bolesnika s ulkusom dva-
naesnika (p < 0,01). Kod svih ispitanika pu{enje nije imalo zna~ajnijeg utjecaja na pri-
sustvo `elu~ane metaplazije. Bolesnici s vrijedom dvanaesnika, koji su bili pu{a~i i
bolesnici koji su bili pu{a~i te imali vrijed dvanaesnika i H. pylori infekciju imali su
zna~ajno ve}u u~estalost `elu~ane metaplazije (p < 0,01). Me|utim, u bolesnika s ulku-
som dvanaesnika nije bilo statisti~ki zna~ajne razlike u prisutnosti `elu~ane metapla-
zije s obzirom na prisustvo Helicobacter pylori. ^ini se da Helicobacter pylori infekcija
nije od presudnog zna~enja u nastanku `elu~ane metaplazije.
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